UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MA06.04 FGF5 Expression in Malignant Pleural Mesothelioma: Impact on Cell Growth, Cisplatin Resistance and Patient Survival

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S153-S153

2021

Volltextzugriff (PDF)

EP14.02-006 Subtype-specific Hypersensitivity to Oxidative Phosphorylation Inhibition in Small Cell Lung Cancer

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S539-S540

2022

Volltextzugriff (PDF)

EP07.01-014 Mesothelioma-Associated Fibroblasts Enhance Mesothelioma Aggressiveness and Modulate Drug Response

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S319

2022

Volltextzugriff (PDF)

EP1.03-31 Cell Migration and Epithelial Mesenchymal Transition in Lung Cancer - Different Roads and Common Themes

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S964-S965

2019

Volltextzugriff (PDF)

EP07.02-001 Evaluation of FGF18 as a Contributing Factor in Malignant Pleural Mesothelioma Growth and Its Role as a Potential Biomarker

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S325-S326

2022

Volltextzugriff (PDF)

P35.01 YB-1 is a Key Player in Aggressive Behaviour and Chemoresistance in Mesothelioma

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1062-S1062

2021

Volltextzugriff (PDF)

EP14.02-002 Cisplatin in Combination with Entinostat exerts Synergistic Antineoplastic Activity in Small Cell Lung Cancer

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S537

2022

Volltextzugriff (PDF)

P2.06-06 Y-box Binding Protein-1, a Potential Target in Malignant Pleural Mesothelioma, Drives Growth Through Distinct Mechanisms

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S757-S757

2019

Volltextzugriff (PDF)

EP14.02-003 Clinical Significance of MYC Family Members in Surgically Resected Limited-Stage Small Cell Lung Cancer: A Multicenter Study

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S537-S538

2022

Volltextzugriff (PDF)

P2.06-16 YB-1: An Important Driver of Mesothelioma Drug Resistance and a Potential Novel Therapeutic Target

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S748-S748

2018

Volltextzugriff (PDF)

P2.06-32 YB-1 - A Key Factor in Mesothelioma Aggressive Growth and Behaviour

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S755-S755

2018

Volltextzugriff (PDF)

P1.09-005 Targeting YB-1 Induces Either Drug Sensitization or Resistance via Distinct Mechanisms in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2019-S2019

2017

Volltextzugriff (PDF)

P1.09-004 YB-1 Suppresses miR-137 via a Feed Forward Loop, Increasing YB-1 Levels, Migration and Invasion in Malignant Mesothelioma

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2019-S2019

2017

Volltextzugriff (PDF)

MA01.04 Molecular Subtypes of Surgically Resected Small Cell Lung Cancer: Expression Pattern and Prognostic Relevance

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S43-S44

2022

Volltextzugriff (PDF)

Cell Migration and Epithelial Mesenchymal Transition in Lung Cancer - Different Roads and Common Themes: EP1.03-31

Journal of thoracic oncology, 2019-10, Vol.14 (10 Suppl), p.S964-S965

2019

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Thoracic Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

MA06.04 FGF5 Expression in Malignant Pleural Mesothelioma: Impact on Cell Growth, Cisplatin Resistance and Patient Survival

EP14.02-006 Subtype-specific Hypersensitivity to Oxidative Phosphorylation Inhibition in Small Cell Lung Cancer

EP07.01-014 Mesothelioma-Associated Fibroblasts Enhance Mesothelioma Aggressiveness and Modulate Drug Response

EP1.03-31 Cell Migration and Epithelial Mesenchymal Transition in Lung Cancer - Different Roads and Common Themes

EP07.02-001 Evaluation of FGF18 as a Contributing Factor in Malignant Pleural Mesothelioma Growth and Its Role as a Potential Biomarker

P35.01 YB-1 is a Key Player in Aggressive Behaviour and Chemoresistance in Mesothelioma

EP14.02-002 Cisplatin in Combination with Entinostat exerts Synergistic Antineoplastic Activity in Small Cell Lung Cancer

P2.06-06 Y-box Binding Protein-1, a Potential Target in Malignant Pleural Mesothelioma, Drives Growth Through Distinct Mechanisms

EP14.02-003 Clinical Significance of MYC Family Members in Surgically Resected Limited-Stage Small Cell Lung Cancer: A Multicenter Study

P2.06-16 YB-1: An Important Driver of Mesothelioma Drug Resistance and a Potential Novel Therapeutic Target

P2.06-32 YB-1 - A Key Factor in Mesothelioma Aggressive Growth and Behaviour

P1.09-005 Targeting YB-1 Induces Either Drug Sensitization or Resistance via Distinct Mechanisms in Malignant Pleural Mesothelioma

P1.09-004 YB-1 Suppresses miR-137 via a Feed Forward Loop, Increasing YB-1 Levels, Migration and Invasion in Malignant Mesothelioma

MA01.04 Molecular Subtypes of Surgically Resected Small Cell Lung Cancer: Expression Pattern and Prognostic Relevance

Cell Migration and Epithelial Mesenchymal Transition in Lung Cancer - Different Roads and Common Themes: EP1.03-31

Aktive Filter

Suchergebnisse filtern